392 related articles for article (PubMed ID: 32284311)
1. Interim results of bleomycin-polidocanol foam sclerotherapy as a highly efficient technique for venous malformations.
Yang X; Chen H; Gu H; Jin Y; Hu L; Hua C; Wang Y; Sun Y; Yu W; Lin X
J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):1066-1073. PubMed ID: 32284311
[TBL] [Abstract][Full Text] [Related]
2. Comparison of polidocanol foam versus bleomycin polidocanol foam for treatment of venous malformations.
He B; Yang B; Nie QQ; Zhang JB; Chen J; Liu P; Fan XQ; Ye ZD
J Vasc Surg Venous Lymphat Disord; 2023 Jan; 11(1):143-148. PubMed ID: 35940448
[TBL] [Abstract][Full Text] [Related]
3. Comparison of bleomycin polidocanol foam vs electrochemotherapy combined with polidocanol foam for treatment of venous malformations.
Liu JW; Ni B; Gao XX; He B; Nie QQ; Fan XQ; Ye ZD; Wen JY; Liu P
J Vasc Surg Venous Lymphat Disord; 2024 Mar; 12(2):101697. PubMed ID: 37890588
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous Sclerotherapy of Large Venous Malformations Using Consecutive Polidocanol and Bleomycin Foam: MR Imaging Volumetric and Quality-of-Life Assessment.
Fraissenon A; Fortin F; Durous V; Chauvel-Picard J; Gleizal A; Viremouneix L; Cabet S; Guibaud L
J Vasc Interv Radiol; 2024 Jan; 35(1):127-136.e1. PubMed ID: 37704038
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of foam sclerotherapy for treatment of low-flow vascular malformations in children.
Markovic JN; Nag U; Shortell CK
J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):1074-1082. PubMed ID: 32284312
[TBL] [Abstract][Full Text] [Related]
6. Bleomycin Polidocanol Foam (BPF) Stability - In Vitro Evidence for the Effectiveness of a Novel Sclerosant for Venous Malformations.
Sun Y; Gu H; Yang X; Cai R; Shang Y; Hu L; Wang Y; Chen H; Lin X
Eur J Vasc Endovasc Surg; 2020 Jun; 59(6):1011-1018. PubMed ID: 32063463
[TBL] [Abstract][Full Text] [Related]
7. Safety and effectiveness of percutaneous sclerotherapy for venous disorders of the labia majora in patients with vascular malformations.
Brill R; Deistung A; Gussew A; Goldann C; Stangl F; Uller W; Rosendahl J; Wildgruber M; Wohlgemuth WA
J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):1083-1089. PubMed ID: 32199800
[TBL] [Abstract][Full Text] [Related]
8. Fluoroscopy-guided foam sclerotherapy with sodium morrhuate for peripheral venous malformations: Preliminary experience.
Li L; Feng J; Zeng XQ; Li YH
J Vasc Surg; 2009 Apr; 49(4):961-7. PubMed ID: 19341886
[TBL] [Abstract][Full Text] [Related]
9. Image Guided Sclerotherapy of Masseteric Venous Malformations.
Kumar S; Bhavana K; Kumar B; Sinha AK; Kumar P
Ann Otol Rhinol Laryngol; 2020 Jun; 129(6):548-555. PubMed ID: 31910645
[TBL] [Abstract][Full Text] [Related]
10. Sclerotherapy for congenital vascular malformations with mixing foam of polidocanol and liquid of bleomycin.
Yang WH; Xiang XJ; Li HL
Phlebology; 2023 Aug; 38(7):451-457. PubMed ID: 37318342
[TBL] [Abstract][Full Text] [Related]
11. Preliminary Experience With More Stable Polidocanol Foam in Sclerotherapy of Head and Neck Venous Malformations.
Chen AW; Liu SH; Huang YY; Wang T
Dermatol Surg; 2018 Nov; 44(11):1421-1426. PubMed ID: 29933299
[TBL] [Abstract][Full Text] [Related]
12. Clinicoradiologic predictors of sclerotherapy response in low-flow vascular malformations.
Bagga B; Goyal A; Das A; Bhalla AS; Kandasamy D; Singhal M; Kairo A
J Vasc Surg Venous Lymphat Disord; 2021 Jan; 9(1):209-219.e2. PubMed ID: 32653406
[TBL] [Abstract][Full Text] [Related]
13. Sclerotherapy after embolization of draining vein: a safe treatment method for venous malformations.
Jin Y; Lin X; Li W; Hu X; Ma G; Wang W
J Vasc Surg; 2008 Jun; 47(6):1292-9. PubMed ID: 18387776
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes and predictors of bleomycin polidocanol foam sclerotherapy treatment response in venous malformations.
Ni B; Liu JW; Fan XQ; He B; Nie QQ; Ye ZD; Liu P; Wen JY
J Int Med Res; 2024 Jan; 52(1):3000605231223441. PubMed ID: 38258803
[TBL] [Abstract][Full Text] [Related]
15. Bleomycin electrosclerotherapy in therapy-resistant venous malformations of the body.
Wohlgemuth WA; Müller-Wille R; Meyer L; Wildgruber M; Guntau M; Heydt SV; Pech M; Zanasi A; Flöther L; Brill R
J Vasc Surg Venous Lymphat Disord; 2021 May; 9(3):731-739. PubMed ID: 33045393
[TBL] [Abstract][Full Text] [Related]
16. Ultrasound-guided polidocanol foam sclerotherapy for treating venous malformations.
Kumar S; Bhavana K; Kumar S; Kumar P
J Clin Ultrasound; 2018 Jan; 46(1):23-31. PubMed ID: 29080330
[TBL] [Abstract][Full Text] [Related]
17. Sclerotherapy Improves Symptoms in Patients with Small and Moderate Diameter Low-Flow Vascular Malformations: A Prospective Cohort Study.
Leal BAN; Procópio RJ; Dardik A; Navarro TP
Ann Vasc Surg; 2023 Feb; 89():68-77. PubMed ID: 37466046
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of polidocanol sclerotherapy in alleviating symptoms in patients with venous malformations.
Guzelbey T; Cingoz M; Erdim C; Mutlu IN; Kılıckesmez O
J Vasc Surg Venous Lymphat Disord; 2024 Mar; 12(2):101698. PubMed ID: 37890587
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous treatment of facial venous malformations: a matched comparison of alcohol and bleomycin sclerotherapy.
Spence J; Krings T; TerBrugge KG; Agid R
Head Neck; 2011 Jan; 33(1):125-30. PubMed ID: 20848431
[TBL] [Abstract][Full Text] [Related]
20. Treatment of low-flow vascular malformations by ultrasound-guided sclerotherapy with polidocanol foam: 24 cases and literature review.
Blaise S; Charavin-Cocuzza M; Riom H; Brix M; Seinturier C; Diamand JM; Gachet G; Carpentier PH
Eur J Vasc Endovasc Surg; 2011 Mar; 41(3):412-7. PubMed ID: 21111641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]